Jeppson Wealth Management, Llc
Source: SEC Form 13F · as of Mar 2026Jeppson Wealth Management, Llc holds 18 biotech & pharma companies tracked by BioSniper, totaling $24.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$24.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,134 | $3.8M |
| JNJJOHNSON & JOHNSON | 13,886 | $3.4M |
| CAHCardinal Health Inc. | 12,144 | $2.6M |
| GILDGILEAD SCIENCES, INC. | 18,256 | $2.5M |
| MRKMerck & Co., Inc. | 20,188 | $2.4M |
| ABBVAbbVie Inc. | 9,918 | $2.2M |
| ABTABBOTT LABORATORIES | 13,659 | $1.4M |
| AMGNAMGEN INC | 3,436 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 19,416 | $1.2M |
| PFEPFIZER INC | 40,683 | $1.1M |
| NVSNovartis AG | 6,038 | $922K |
| SNYSanofi | 8,275 | $399K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,244 | $337K |
| NVONovo Nordisk A/S | 9,019 | $331K |
| MRNAModerna, Inc. | 4,762 | $242K |
| AZNASTRAZENECA PLC | 1,041 | $205K |
| RZLTRezolute, Inc. | 10,001 | $31K |
| SNDLSNDL Inc. | 20,000 | $26K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.